Explore the words cloud of the CKDSens project. It provides you a very rough idea of what is the project "CKDSens" about.
The following table provides information about the project.
CREATSENS HEALTH SOCIEDAD LIMITADA
|Coordinator Country||Spain [ES]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
|Duration (year-month-day)||from 2019-03-01 to 2019-08-31|
Take a look of project's partnership.
|1||CREATSENS HEALTH SOCIEDAD LIMITADA||ES (TARRAGONA)||coordinator||50˙000.00|
Frequent monitoring of the renal function is required for hundreds of millions of people (90m in the EU): patients suffering from chronic kidney disease (CKD), diabetes and cardiovascular problems. The monitoring of these patients is still mostly done in hospitals, because the technology involved is too specialized to be handled by patients. Some companies offer limited qualitative monitoring in a near-patient care scenario, but quantitative monitoring is still centralized at hospitals. In this market, CDKSens can make a notable difference.
CreatSens, a technology-based company from Spain, is developing a new point-of-care platform for the personalized management of the kidney function. CKDSens aims to improve current healthcare by introducing new synthetic membranes to detect several relevant biomarkers. CKDSens is a low-cost innovation requiring little expertise, ideal in a near-patient care scenario. By decentralizing the biomarkers’ analysis with new diagnostic systems (i.e. moving it from the hospital to the patient’s home), healthcare professionals will waste less time and money on analyses. This helps sustain our healthcare system. Individual patients will be able to lead a more active life, while health inequalities get tackled along the way. Direct stakeholders are pharmaceutical companies, technological healthcare companies and foundations.
CreatSens wants to assess the technological and economic viability in the first 6 months (phase 1), to deliver a feasibility plan for phase 2 where the key steps for CreatSens to grow as a company in the European context will be introduced. CreatSens' 5-year growth plan is focused on selling the technology in 5 EU countries. We foresee 40 M€ turnover in the next 5 years, with the creation of 50 direct jobs and over 100 indirect jobs.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CKDSENS" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "CKDSENS" are provided by the European Opendata Portal: CORDIS opendata.